CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Lidocaine 7% + Tetracaine 7% creamdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01545765
NCT01545765Phase 4Completed

Anesthetic Effect Duration Produced by Lidocaine 7% + Tetracaine 7% Cream on 2 Different Body Areas

Galderma R&D·interventional·Posted Mar 7, 2012·Updated Sep 2, 2021

In Brief

A Phase 4 clinical trial evaluating Lidocaine 7% + Tetracaine 7% cream for Healthy Volunteers. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the duration of anesthetic effect produced , Lidocaine7% + Tetracaine 7% cream when applied with 2 different application times on the face and thigh.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 7, 2012
Enrollment StartMay 1, 2012
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 14.3 years ago

Interventions

Lidocaine 7% + Tetracaine 7% creamdrug

Study drug will be applied with a different application time to one side of the face and anterior thigh according to the randomization list.